210 похожих чатов

2 ответов

12 просмотров

My point is the teams kpi with the deploys, maybe are different with what we as holders expect... Just that. We as holders expect to see an instant increase in the xvs price... Could happen if only one deploy has the acceptance, colabs and back up as bsc had.... But, the team aims for the protocols growth, have more tvl, better revenue.. Etc. The protocol made money when xvs was ar 3usd oe lower

J.C.-jc Автор вопроса

Похожие вопросы

Обсуждают сегодня

Карта сайта